HIV news

At the British HIV Association (BHIVA) conference, Dr Kate Childs from King's College Hospital, London talks to NAM aidsmap's Roger Pebody about the study she presented on loss to follow-up in south London clinics. This study was presented at BHIVA 2022.

Professor Joel Palefsky from the University of California San Francisco talks about the ANCHOR trial, which has showed that screening and early treatment reduces anal cancer in people with HIV. This study was presented at CROI 2022.

Dr Roger Shapiro from Harvard University talks about antibody treatment for children with HIV and could it be used instead of pills. This study was presented at CROI 2022.

Professor Yvonne Bryson from the University of California Los Angeles talks about the woman in New York who has no detectable HIV 14 months after stopping antiretroviral therapy following a stem-cell transplant for leukaemia. This case was presented to CROI 2022.

Elena Vovc from the World Health Organization talks about the COVID-19 pandemic and how it has impacted HIV diagnoses, treatment and prevention. Elena presented these findings at a session at the EACS 2021 conference.

A new study shows that people with HIV with CD4 counts below 200 produce weaker responses to COVID-19 vaccines than people with better immune function. Dr Andrea Antinori of the National Institute for Infectious Diseases, Italy, talks about the research presented to the EACS 2021 conference.

NAM aidsmap's Susan Cole gives the keynote address of the closing session of the IAS 2021 conference: 'How do we continue to unite policy, science and activism in an increasingly fragmented world?'

Dr Maggie Czarnogorski of ViiV Healthcare talks about providing injectable HIV treatment. This study was presented at the IAS 2021 conference.

Dr Lulu Nair of Stellenbosch University in Cape Town talks about vaginal rings and oral pre-exposure prophylaxis (PrEP). This study was presented at the IAS 2021 conference.

Dr Silvia Bertagnolio of the World Health Organization talks about COVID-19 in people living with HIV. This study was presented at the IAS 2021 conference.

Professor Samir Gupta of Indiana University talks about lenacapavir, an experimental capsid inhibitor, for people starting HIV treatment. This study on lenacapavir was presented at the IAS 2021 conference.

Professor Jean-Michel Molina of Hôpital Saint-Louis in Paris talks about injectable lenacapavir, a capsid inhibitor currently under development, for people with multidrug-resistant HIV. This study on lenacapavir was presented at the IAS 2021 conference.

A vaginal ring containing the anti-HIV medication dapivirine provides a new HIV prevention option for women. Dr Zeda Rosenburg from the International Partnership for Microbicides tells us about the ring being approved by regulators and plans for its roll-out in sub-Saharan Africa.

According to a report presented at the AIDS 2020 conference, a man in São Paulo had no evidence of remaining HIV after more than 15 months off antiretrovirals. Dr Andrea Savarino from the Instituto Superiore di Sanita in Rome talks to NAM aidsmap.

Our HIV Community Forum shared information on HIV treatment and prevention from the 9th IAS Conference on HIV Science. With Dr Tristan Barber, from Chelsea and Westminster NHS Foundation Trust; Memory Sachikonye, from UK Community Advisory Board (UK-CAB); and Gus Cairns and Roger Pebody, from NAM aidsmap.